Avandia Insurers Denied Class Cert. In Suit Against Glaxo
A Pennsylvania federal judge on Monday denied class certification to two Humana Inc. units that sued GlaxoSmithKline PLC for the cost of insuring Medicare patients harmed by its drug Avandia, saying...To view the full article, register now.
Already a subscriber? Click here to view full article